ViewRay, Inc. (NasdaqGM:VRAY) which makes the MRIdian radiation-therapy system for cancer patients, said it has filed for bankruptcy after years of unprofitable operations, and plans to sell some or all of its assets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.28% | 0.00% | 0.00% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 12 | Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products | MT |
1st Jan change | Capi. | |
---|---|---|
0.00% | 25.31K | |
+7.15% | 220B | |
+6.60% | 183B | |
+9.86% | 133B | |
+24.32% | 107B | |
-0.95% | 63.05B | |
+11.04% | 51.74B | |
+4.81% | 50.47B | |
-1.43% | 40.91B | |
+24.40% | 31.91B |
- Stock Market
- Equities
- VRAYQ Stock
- News ViewRay, Inc.
- ViewRay Plans to Pursue Sale